Measurement of hippocampal volume has proven useful to diagnose and track progression in several brain disorders, most notably in Alzheimer's disease (AD). For example, an objective evaluation of a patient's hippocampal volume status may provide important information that can assist diagnosis or risk stratification of AD. However, clinicians and researchers require access to age-related normative percentiles to reliably categorise a patient's hippocampal volume as being pathologically small. Here we analysed effects of age, sex, and hemisphere on the hippocampus and neighbouring temporal lobe volumes, in 19,793 generally healthy participants in the UK Biobank. A key finding of the current study is a significant acceleration in the rate of h...
Background: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impai...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
<p>MCI, mild cognitive impairment; AD, Alzheimer’s disease. Volume loss was approximately 1% in heal...
Reduced volumes of the hippocampus (HC) and amygdala (AG) are potential biomarkers for Alzheimer's d...
Magnetic Resonance Imaging (MRI) provides a noninvasive method for investigating brain morphology. W...
Alzheimer's disease is characterized by hippocampal atrophy. Other factors also influence the hippoc...
Alzheimer's disease is characterized by hippocampal atrophy. Other factors also influence the hippoc...
OBJECTIVES: Volumetric reductions in the hippocampus and the amygdala are considered a hallmark for ...
Background/Aims: To evaluate the relationship between hippocampal volume and cognitive decline in pa...
Background: Hippocampal volume is affected by several psychiatric illnesses of old age, as well as b...
Female sex, age and carriage of the apolipoprotein E e4 allele are the greatest risk factors for spo...
Background: Hippocampal volume is affected by several psychiatric illnesses of old age, as well as b...
MRI-based hippocampal volume analysis has been extensively employed given its potential as a biomark...
The hippocampus is one of the first regions to demonstrate atrophy during the prodromal stage of Alz...
BACKGROUND: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impai...
Background: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impai...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
<p>MCI, mild cognitive impairment; AD, Alzheimer’s disease. Volume loss was approximately 1% in heal...
Reduced volumes of the hippocampus (HC) and amygdala (AG) are potential biomarkers for Alzheimer's d...
Magnetic Resonance Imaging (MRI) provides a noninvasive method for investigating brain morphology. W...
Alzheimer's disease is characterized by hippocampal atrophy. Other factors also influence the hippoc...
Alzheimer's disease is characterized by hippocampal atrophy. Other factors also influence the hippoc...
OBJECTIVES: Volumetric reductions in the hippocampus and the amygdala are considered a hallmark for ...
Background/Aims: To evaluate the relationship between hippocampal volume and cognitive decline in pa...
Background: Hippocampal volume is affected by several psychiatric illnesses of old age, as well as b...
Female sex, age and carriage of the apolipoprotein E e4 allele are the greatest risk factors for spo...
Background: Hippocampal volume is affected by several psychiatric illnesses of old age, as well as b...
MRI-based hippocampal volume analysis has been extensively employed given its potential as a biomark...
The hippocampus is one of the first regions to demonstrate atrophy during the prodromal stage of Alz...
BACKGROUND: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impai...
Background: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impai...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
<p>MCI, mild cognitive impairment; AD, Alzheimer’s disease. Volume loss was approximately 1% in heal...